Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
10(90.9%)
Phase 4
1(9.1%)
11Total
N/A(10)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded